Morning Briefing
Summaries of health policy coverage from major news organizations
First Vaccine Could Be Administered In US As Early As Dec. 11
CNN: White House Vaccine Chief Says First Americans Could Be Vaccinated Next Month
Moncef Slaoui, the head of the US government's effort to develop a vaccine against Covid-19, said the first Americans to receive a vaccine -- if all things go according to plan -- could be as early as the second week of December. "Our plan is to be able to ship vaccines to the immunization sites within 24 hours from the approval, so I would expect maybe on day two after approval, on the 11th or on the 12th of December, hopefully, the first people will be immunized across the United States, across all states, in all the areas where the State Departments of Health will have told us where to deliver the vaccine," Slaoui told CNN's Jake Tapper on "State of the Union" Sunday. (Thomas and Janfaza, 11/22)
Reuters: COVID-19 Shots Could Reach First Americans By Mid-December, Top Health Official Says
U.S. healthcare workers and others recommended for the nation’s first COVID-19 inoculations could start getting shots within a day or two of regulatory consent next month, a top official of the government’s vaccine development effort said on Sunday. Some 70% of the U.S. population of 330 million would need to be inoculated to achieve “herd” immunity from the virus, a goal the country could achieve by May, according to Dr. Moncef Slaoui, chief scientific adviser for “Operation Warp Speed.” (11/22)
NPR: Americans Could See A Vaccine By Mid-December, Says Operation Warp Speed Adviser
Slaoui's comments follow the announcement on Friday that Pfizer and its partner, BioNTech, have asked the Food and Drug Administration to grant an emergency use authorization for its COVID-19 vaccine — which has been found to be 95% effective. A second vaccine from the biotech company Moderna is expected to be submitted for emergency authorization soon as well. (Silva, 11/22)
Also —
Politico: 'The Train Is Running' On Covid Vaccines Despite Transition Delay, Warp Speed Adviser Says
The delay in the presidential transition process won't impact the work of Operation Warp Speed, the public-private partnership to develop coronavirus vaccines, the operation's chief adviser said Sunday. "Frankly, the operation has been isolated from, from the administration, from the political environment and the political context," Moncef Slaoui said on NBC's "Meet the Press." "We worked very hard to make sure that’s the case. And therefore, all decisions are made, the train is running, whether one administration or the other doesn’t, frankly, make a difference. I hope there is no disruption in any way." (Parthasarathy, 11/22)
The Hill: Vaccine Czar: 'Unfortunate' That COVID-19 Vaccine 'Has Been Politicized'
The chief adviser to the Trump administration’s Operation Warp Speed said Sunday that it is “unfortunate” that the COVID-19 vaccine “has been politicized.” Moncef Slaoui during an interview with CNN’s “State of the Union” attributed polls showing a decreased public willingness to be inoculated against COVID-19 to the process being “politicized.” (Coleman, 11/22)
